Abstract
Tacrolimus (TAC) is highly effective at preventing rejection and prolonging graft function in heart transplant (HT) recipients. The nephrotoxic effect of TAC remains one of its most significant limitations. TAC induced nephrotoxicity is strongly associated with the concentration of TAC in whole blood; emerging data suggests that the rate of drug metabolism may also contribute. The ratio of TAC blood concentration to TAC dose (C/D ratio) has been shown to be a reliable marker for the rate of metabolism in renal transplant recipients, but has not been evaluated in HT patients. This study aimed to characterize the relationship between the rate of TAC metabolism and its effects on renal function in HT recipients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
